| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbital Diseases | 6 | 2013 | 181 | 1.400 |
Why?
|
| Eyelid Neoplasms | 4 | 2013 | 94 | 1.100 |
Why?
|
| Ophthalmologic Surgical Procedures | 8 | 2019 | 349 | 1.100 |
Why?
|
| Eyelid Diseases | 6 | 2013 | 155 | 1.000 |
Why?
|
| Meibomian Glands | 8 | 2018 | 85 | 0.950 |
Why?
|
| Lacrimal Apparatus | 4 | 2017 | 225 | 0.880 |
Why?
|
| Chalazion | 3 | 2018 | 13 | 0.800 |
Why?
|
| Conjunctiva | 5 | 2017 | 494 | 0.740 |
Why?
|
| Dacryocystitis | 2 | 2010 | 70 | 0.670 |
Why?
|
| Orbital Cellulitis | 2 | 2009 | 33 | 0.640 |
Why?
|
| Triamcinolone Acetonide | 2 | 2018 | 101 | 0.620 |
Why?
|
| Glucocorticoids | 6 | 2018 | 2107 | 0.600 |
Why?
|
| Ectropion | 1 | 2017 | 26 | 0.590 |
Why?
|
| Blepharoptosis | 2 | 2010 | 143 | 0.580 |
Why?
|
| Orbital Neoplasms | 5 | 2008 | 225 | 0.570 |
Why?
|
| Eye Burns | 1 | 2017 | 103 | 0.550 |
Why?
|
| Burns, Chemical | 1 | 2017 | 159 | 0.530 |
Why?
|
| Eyelids | 4 | 2018 | 265 | 0.520 |
Why?
|
| Graves Disease | 3 | 2008 | 242 | 0.510 |
Why?
|
| Graves Ophthalmopathy | 2 | 2008 | 117 | 0.490 |
Why?
|
| Orbit | 4 | 2006 | 426 | 0.490 |
Why?
|
| Mouth Mucosa | 1 | 2017 | 434 | 0.480 |
Why?
|
| Eye Infections, Bacterial | 2 | 2008 | 235 | 0.470 |
Why?
|
| Xanthomatosis | 1 | 2013 | 32 | 0.460 |
Why?
|
| Mucocele | 1 | 2013 | 49 | 0.460 |
Why?
|
| Epidermal Cyst | 2 | 2010 | 62 | 0.450 |
Why?
|
| Casts, Surgical | 1 | 2014 | 178 | 0.450 |
Why?
|
| Dermoid Cyst | 1 | 2013 | 93 | 0.440 |
Why?
|
| Eye Injuries | 3 | 2005 | 245 | 0.420 |
Why?
|
| Choristoma | 1 | 2013 | 213 | 0.410 |
Why?
|
| Fracture Fixation | 1 | 2014 | 354 | 0.410 |
Why?
|
| Radius Fractures | 2 | 2014 | 501 | 0.400 |
Why?
|
| Oculomotor Muscles | 2 | 2008 | 371 | 0.380 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 427 | 0.370 |
Why?
|
| Thyroiditis | 1 | 2010 | 85 | 0.370 |
Why?
|
| Dacryocystorhinostomy | 3 | 2019 | 72 | 0.370 |
Why?
|
| Orbital Pseudotumor | 2 | 2011 | 42 | 0.360 |
Why?
|
| Blepharoplasty | 2 | 2010 | 50 | 0.360 |
Why?
|
| Refractive Surgical Procedures | 1 | 2010 | 25 | 0.360 |
Why?
|
| Eye Proteins | 2 | 2014 | 646 | 0.350 |
Why?
|
| Conjunctival Diseases | 2 | 2008 | 122 | 0.340 |
Why?
|
| Eye Evisceration | 1 | 2009 | 23 | 0.340 |
Why?
|
| Addison Disease | 1 | 2009 | 48 | 0.330 |
Why?
|
| Postoperative Complications | 9 | 2017 | 15295 | 0.330 |
Why?
|
| Entropion | 1 | 2008 | 10 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 1790 | 0.320 |
Why?
|
| Lacrimal Duct Obstruction | 2 | 2019 | 48 | 0.310 |
Why?
|
| Ethmoid Sinusitis | 1 | 2007 | 25 | 0.300 |
Why?
|
| Orbital Fractures | 3 | 2007 | 110 | 0.300 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 2008 | 123 | 0.290 |
Why?
|
| Muscle Neoplasms | 1 | 2008 | 139 | 0.290 |
Why?
|
| Skin Diseases | 2 | 2013 | 1065 | 0.280 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2008 | 108 | 0.280 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 232 | 0.280 |
Why?
|
| Eye Foreign Bodies | 1 | 2006 | 55 | 0.270 |
Why?
|
| Blindness | 2 | 2007 | 617 | 0.270 |
Why?
|
| Eye Diseases | 2 | 2019 | 669 | 0.270 |
Why?
|
| Orbit Evisceration | 1 | 2005 | 8 | 0.270 |
Why?
|
| Cataract Extraction | 1 | 2010 | 481 | 0.260 |
Why?
|
| Rhabdomyosarcoma | 1 | 2008 | 382 | 0.260 |
Why?
|
| Orthopedics | 1 | 2014 | 904 | 0.260 |
Why?
|
| Student Dropouts | 1 | 2004 | 27 | 0.250 |
Why?
|
| Granuloma, Pyogenic | 1 | 2005 | 48 | 0.250 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2010 | 545 | 0.250 |
Why?
|
| Compartment Syndromes | 1 | 2007 | 153 | 0.250 |
Why?
|
| Suture Techniques | 1 | 2010 | 798 | 0.250 |
Why?
|
| Epithelial Cells | 6 | 2018 | 3690 | 0.250 |
Why?
|
| Abscess | 1 | 2008 | 607 | 0.250 |
Why?
|
| Boric Acids | 1 | 2004 | 7 | 0.240 |
Why?
|
| Pentosan Sulfuric Polyester | 1 | 2004 | 8 | 0.240 |
Why?
|
| Thimerosal | 1 | 2004 | 16 | 0.240 |
Why?
|
| Ocular Hypotension | 1 | 2004 | 22 | 0.240 |
Why?
|
| Emphysema | 1 | 2007 | 247 | 0.240 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2008 | 506 | 0.240 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 638 | 0.230 |
Why?
|
| Ophthalmic Solutions | 2 | 2008 | 317 | 0.230 |
Why?
|
| Prodrugs | 1 | 2005 | 268 | 0.230 |
Why?
|
| Corneal Edema | 1 | 2004 | 52 | 0.230 |
Why?
|
| Mycophenolic Acid | 1 | 2005 | 343 | 0.230 |
Why?
|
| Phenylephrine | 1 | 2004 | 301 | 0.220 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 134 | 0.220 |
Why?
|
| Endoscopy | 2 | 2017 | 1785 | 0.220 |
Why?
|
| Multiple Trauma | 1 | 2005 | 367 | 0.210 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2005 | 213 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 233 | 0.200 |
Why?
|
| Dexamethasone | 1 | 2009 | 1951 | 0.200 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2002 | 117 | 0.200 |
Why?
|
| Decompression, Surgical | 2 | 2005 | 594 | 0.190 |
Why?
|
| Wound Healing | 3 | 2006 | 2785 | 0.190 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2942 | 0.180 |
Why?
|
| Immunoenzyme Techniques | 3 | 2013 | 1799 | 0.180 |
Why?
|
| Gene Expression | 2 | 2012 | 7799 | 0.180 |
Why?
|
| Exophthalmos | 3 | 2011 | 97 | 0.170 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2019 | 65 | 0.160 |
Why?
|
| Face | 1 | 2005 | 994 | 0.160 |
Why?
|
| Nystagmus, Pathologic | 1 | 1999 | 96 | 0.160 |
Why?
|
| Humans | 68 | 2019 | 744343 | 0.160 |
Why?
|
| Ophthalmology | 1 | 2004 | 508 | 0.160 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 137 | 0.160 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2018 | 192 | 0.160 |
Why?
|
| Career Choice | 1 | 2004 | 744 | 0.160 |
Why?
|
| Granuloma | 2 | 2019 | 319 | 0.160 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1998 | 58 | 0.150 |
Why?
|
| Ganciclovir | 1 | 1998 | 258 | 0.150 |
Why?
|
| Eye Neoplasms | 1 | 2019 | 313 | 0.150 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 1451 | 0.140 |
Why?
|
| Visual Acuity | 5 | 2010 | 2530 | 0.140 |
Why?
|
| Eye Abnormalities | 1 | 1999 | 246 | 0.140 |
Why?
|
| Retinal Diseases | 1 | 2002 | 683 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2013 | 20129 | 0.140 |
Why?
|
| Female | 38 | 2019 | 380194 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1400 | 0.130 |
Why?
|
| Regeneration | 1 | 2005 | 1485 | 0.130 |
Why?
|
| Tissue Adhesions | 1 | 2017 | 235 | 0.130 |
Why?
|
| Skin Aging | 2 | 2009 | 127 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2282 | 0.130 |
Why?
|
| Pharmaceutical Preparations | 1 | 2004 | 1071 | 0.130 |
Why?
|
| Aged | 24 | 2019 | 163280 | 0.130 |
Why?
|
| Manipulation, Orthopedic | 1 | 2014 | 43 | 0.120 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2012 | 428 | 0.120 |
Why?
|
| Male | 37 | 2019 | 350118 | 0.120 |
Why?
|
| Middle Aged | 24 | 2019 | 213383 | 0.120 |
Why?
|
| Debridement | 2 | 2008 | 492 | 0.120 |
Why?
|
| Keratin-17 | 1 | 2013 | 26 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1998 | 657 | 0.120 |
Why?
|
| Keratin-18 | 1 | 2013 | 39 | 0.120 |
Why?
|
| Conjunctival Neoplasms | 2 | 2005 | 79 | 0.120 |
Why?
|
| Glaucoma Drainage Implants | 2 | 2005 | 116 | 0.110 |
Why?
|
| Tissue Extracts | 1 | 2013 | 135 | 0.110 |
Why?
|
| Serum | 1 | 2014 | 214 | 0.110 |
Why?
|
| Radiography | 4 | 2014 | 7023 | 0.110 |
Why?
|
| Enophthalmos | 3 | 2008 | 34 | 0.110 |
Why?
|
| Muramidase | 1 | 2012 | 174 | 0.110 |
Why?
|
| Speech | 1 | 2017 | 540 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2012 | 97 | 0.100 |
Why?
|
| Nasolacrimal Duct | 2 | 2019 | 74 | 0.100 |
Why?
|
| Orbital Myositis | 1 | 2011 | 20 | 0.100 |
Why?
|
| Hypergammaglobulinemia | 1 | 2011 | 74 | 0.100 |
Why?
|
| Adult | 25 | 2019 | 214055 | 0.100 |
Why?
|
| Lipocalins | 1 | 2012 | 170 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 1999 | 1416 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1596 | 0.100 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2011 | 55 | 0.100 |
Why?
|
| Goblet Cells | 1 | 2013 | 287 | 0.090 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 553 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 57776 | 0.090 |
Why?
|
| Bone Plates | 1 | 2013 | 468 | 0.090 |
Why?
|
| Sclerosis | 1 | 2010 | 213 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 2013 | 708 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 2013 | 665 | 0.090 |
Why?
|
| Internship and Residency | 2 | 2014 | 5788 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2002 | 2400 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2008 | 8642 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 2699 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2011 | 4560 | 0.080 |
Why?
|
| Haemophilus paraphrophilus | 1 | 2008 | 2 | 0.080 |
Why?
|
| Lasers, Semiconductor | 1 | 2009 | 46 | 0.080 |
Why?
|
| Eikenella corrodens | 1 | 2008 | 18 | 0.080 |
Why?
|
| Fracture Fixation, Internal | 2 | 2013 | 917 | 0.080 |
Why?
|
| Cloprostenol | 1 | 2008 | 22 | 0.080 |
Why?
|
| Streptococcus anginosus | 1 | 2008 | 24 | 0.080 |
Why?
|
| Retrospective Studies | 13 | 2019 | 77449 | 0.080 |
Why?
|
| Facial Dermatoses | 1 | 2009 | 87 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 644 | 0.080 |
Why?
|
| Cutis Laxa | 1 | 2008 | 29 | 0.080 |
Why?
|
| Corneal Ulcer | 1 | 2009 | 169 | 0.070 |
Why?
|
| Chromogranins | 1 | 2008 | 160 | 0.070 |
Why?
|
| Glaucoma | 3 | 2008 | 1159 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2010 | 591 | 0.070 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2007 | 44 | 0.070 |
Why?
|
| Cosmetic Techniques | 1 | 2009 | 135 | 0.070 |
Why?
|
| Thyroxine | 1 | 2010 | 667 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4189 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2008 | 569 | 0.070 |
Why?
|
| Dry Eye Syndromes | 1 | 2011 | 386 | 0.070 |
Why?
|
| Fatal Outcome | 2 | 2008 | 1850 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2018 | 10481 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2010 | 981 | 0.070 |
Why?
|
| Eosinophils | 1 | 2010 | 955 | 0.070 |
Why?
|
| Gene Transfer Techniques | 2 | 2002 | 1224 | 0.070 |
Why?
|
| Mohs Surgery | 1 | 2008 | 197 | 0.070 |
Why?
|
| Phototherapy | 1 | 2009 | 377 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 12072 | 0.070 |
Why?
|
| Zygomatic Fractures | 1 | 2005 | 37 | 0.070 |
Why?
|
| Nafcillin | 1 | 2005 | 25 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2018 | 11483 | 0.070 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2007 | 115 | 0.070 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2008 | 245 | 0.070 |
Why?
|
| Ophthalmic Artery | 1 | 2005 | 60 | 0.070 |
Why?
|
| Amides | 1 | 2008 | 459 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 1998 | 2987 | 0.060 |
Why?
|
| Stem Cells | 1 | 2018 | 3567 | 0.060 |
Why?
|
| Rupture | 2 | 2005 | 433 | 0.060 |
Why?
|
| Ethmoid Sinus | 1 | 2004 | 58 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2263 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3749 | 0.060 |
Why?
|
| Retrobulbar Hemorrhage | 1 | 2002 | 11 | 0.060 |
Why?
|
| Maxillary Sinus | 1 | 2004 | 180 | 0.060 |
Why?
|
| Genes, BRCA2 | 1 | 2006 | 618 | 0.050 |
Why?
|
| Drainage | 1 | 2008 | 1142 | 0.050 |
Why?
|
| Hemangioma, Cavernous | 1 | 2002 | 110 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2291 | 0.050 |
Why?
|
| Massachusetts | 3 | 2005 | 8663 | 0.050 |
Why?
|
| Intraocular Pressure | 2 | 2004 | 1270 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2005 | 662 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2008 | 2634 | 0.050 |
Why?
|
| Fever | 1 | 2009 | 1616 | 0.050 |
Why?
|
| Young Adult | 4 | 2017 | 56430 | 0.050 |
Why?
|
| Lacerations | 1 | 2002 | 144 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2009 | 1640 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 6489 | 0.050 |
Why?
|
| Wounds, Penetrating | 1 | 2002 | 307 | 0.050 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2002 | 233 | 0.040 |
Why?
|
| Lipid Metabolism | 3 | 2014 | 1889 | 0.040 |
Why?
|
| Perception | 1 | 2006 | 1198 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2004 | 642 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2006 | 2290 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 9438 | 0.040 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1999 | 220 | 0.040 |
Why?
|
| Scleral Buckling | 1 | 1999 | 84 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 2046 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2008 | 7181 | 0.040 |
Why?
|
| Laser Therapy | 1 | 2005 | 1072 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 1959 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2004 | 547 | 0.040 |
Why?
|
| Meningioma | 1 | 2007 | 1209 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 520 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2007 | 1241 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2010 | 3420 | 0.040 |
Why?
|
| S100 Proteins | 2 | 2011 | 259 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4665 | 0.040 |
Why?
|
| Deoxyribonucleases | 1 | 2018 | 214 | 0.040 |
Why?
|
| Drug Implants | 1 | 1998 | 244 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 3616 | 0.040 |
Why?
|
| Incidence | 3 | 2005 | 20947 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11366 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39050 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2008 | 3279 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2019 | 63114 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2001 | 2297 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3703 | 0.030 |
Why?
|
| Reoperation | 2 | 2017 | 4201 | 0.030 |
Why?
|
| Adolescent | 5 | 2014 | 85781 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 19229 | 0.030 |
Why?
|
| Skin | 1 | 2009 | 4364 | 0.030 |
Why?
|
| Age Distribution | 1 | 2001 | 2902 | 0.030 |
Why?
|
| Retinal Detachment | 1 | 1999 | 411 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 1998 | 968 | 0.030 |
Why?
|
| Photography | 2 | 2008 | 520 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 4986 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10180 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4751 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6756 | 0.030 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2011 | 10 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2004 | 2657 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 10397 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2618 | 0.020 |
Why?
|
| Recurrence | 2 | 2005 | 8340 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2005 | 9146 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 4266 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2006 | 4838 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2010 | 258 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 893 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 21827 | 0.020 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 3396 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1856 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6364 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 693 | 0.020 |
Why?
|
| Device Removal | 1 | 2013 | 656 | 0.020 |
Why?
|
| Rejuvenation | 1 | 2009 | 91 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 1243 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2011 | 881 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3768 | 0.020 |
Why?
|
| Inflammation | 1 | 2007 | 10638 | 0.020 |
Why?
|
| Salpingostomy | 1 | 2006 | 11 | 0.020 |
Why?
|
| Prednisone | 1 | 2011 | 1574 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 1578 | 0.020 |
Why?
|
| Melanoma | 1 | 2005 | 5510 | 0.020 |
Why?
|
| Heart Diseases | 1 | 1999 | 2788 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2008 | 690 | 0.020 |
Why?
|
| Child | 3 | 2005 | 77709 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 1999 | 5317 | 0.020 |
Why?
|
| Filtering Surgery | 1 | 2005 | 35 | 0.020 |
Why?
|
| Intubation | 1 | 2005 | 141 | 0.020 |
Why?
|
| Telomerase | 1 | 2010 | 730 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2013 | 2967 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 35421 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2007 | 1030 | 0.010 |
Why?
|
| Tears | 1 | 2005 | 256 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 15226 | 0.010 |
Why?
|
| United States | 2 | 2019 | 69872 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2006 | 661 | 0.010 |
Why?
|
| Retreatment | 1 | 2005 | 610 | 0.010 |
Why?
|
| Disabled Persons | 1 | 2013 | 1212 | 0.010 |
Why?
|
| Atrophy | 1 | 2008 | 1583 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12959 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
| Cell Division | 1 | 2010 | 4568 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1678 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2011 | 1580 | 0.010 |
Why?
|
| Limbus Corneae | 1 | 2004 | 144 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
| Bone Screws | 1 | 2005 | 520 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 29786 | 0.010 |
Why?
|
| Hysterectomy | 1 | 2006 | 927 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14557 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 81183 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 53288 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 13033 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 41006 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 11727 | 0.010 |
Why?
|
| Health Surveys | 1 | 2007 | 4037 | 0.010 |
Why?
|
| Cornea | 1 | 2004 | 1524 | 0.010 |
Why?
|
| Transgenes | 1 | 1999 | 1009 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 1999 | 841 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 168757 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
| Health Personnel | 1 | 2008 | 3218 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2007 | 3748 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7880 | 0.010 |
Why?
|
| Quality of Life | 1 | 2013 | 12804 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40075 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 13989 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 19905 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 23338 | 0.000 |
Why?
|
| Depression | 1 | 2007 | 7766 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9849 | 0.000 |
Why?
|
| DNA | 1 | 1999 | 7301 | 0.000 |
Why?
|
| Comorbidity | 1 | 1999 | 10388 | 0.000 |
Why?
|
| Risk Factors | 1 | 2005 | 72290 | 0.000 |
Why?
|